Enveric Biosciences Inc vs Waste Management, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Waste Management, Inc. trades at $242.62 (market cap $93.49B). The key difference: Waste Management, Inc. is far larger — about 17573.3× Enveric Biosciences Inc's market cap, and Waste Management, Inc. pays a 1.52% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | WM | |
|---|---|---|
Market Cap | $5.32M | $93.49B |
Sector | Health | Industrials |
52-Week High | $17.40 | $246.51 |
52-Week Low | $1.28 | $196.77 |
Enterprise Value | $408.82K | $116.22B |
Dividend Yield | — | 1.52% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
WM trades at $242.56, up 3.54% today and near its 52-week high, with a bullish technical signal from moving averages. The company reported $25.20B revenue in 2025, with a net income margin of 10.99%, though recent quarters show mixed EPS performance. Strong cash flow from operations of $6.04B supports dividend payments, including a recent $0.95 per share distribution.
Outlook remains positive with a consensus price target of $264.17, reflecting analyst confidence in WM's pricing power and renewable energy initiatives. Key risks include elevated debt levels and potential economic sensitivity. The stock offers stability with growth potential, but investors should monitor execution against earnings expectations.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →